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Ctostridium difficile, recognized as a major cause of 
antibiotic-associated pseudomembranous enterocolitis~ 
produces two toxins: toxin A and B. Toxin B is an 
extremely potent cytotoxin (for review see [1]). The 
toxin B gene has been sequenced [2,3]. Knoop et al. [4] 
showed that toxin B has enolase activity as measured by 
degradation of 2-phosphoglycerate. H re we show that 
toxin B does not have enolase activity. 
Amino acid sequences of three tryptic peptides ob- 
tained from presumed toxin B showed homology to 
~-enolase of the rat and enolase of Saccharon~vces cere- 
visiae [5]. These sequences were compared with the 
amino acid sequence of toxin B deduced from the DNA 
sequence and showed no homology. The tryptic pep- 
tides were obtained from a protein with a relative mo- 
lecular mass of 52 kDa under denaturing conditions. 
The Toxin B preparation (MW 163 kDa on SDS- 
PAGE) showed enolase activity [12]. However, the ex- 
pected molecular weight is 270 kDa [3]. 
These discrepancies led us to study the presence of 
enolase activity in culture supernatants of toxigenic and 
nontoxigenic strains of C difficile (obtained from the 
American Type Culture Collection (ATCC 9689, 43593, 
43594, and 43596 through 43603)). Culture superna- 
rants from six C. difficile strains which produced toxin 
and contained the genes for both toxin A and B, and five 
strains which possessed neither the toxin A nor the toxin 
B gene and were not toxigenic [6], were assayed for 
enolase activity. Both toxigenic and nontoxigenic 
strains of C. difficile produced enolase activity in the 
culture supernatant. 
Partial purification of culture supernatant over 
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DEAE-Sepharose CL-6B showed co-elution of cytotox- 
icity and enolase activity. However, enolase activity was 
also demonstrated in the fraction containing unbound 
proteins. When culture supernatants of nontoxigenic 
strains were used enolase activity was only recovered in 
the fraction containing unbound proteins. 
Further purification of pooled fractions containing 
cytotoxicity on a Sephacryl $300 gel filtration column 
also showed co-elution of toxicity and enolase activity. 
This is in agreement with literature where it has been 
reported that enolase activity copurifies with toxin B in 
a wide variety of purification methods including 
(NH4)2SO4 precipitation, Biogel A5m gelfiltration, 
phenylboronate column chromatography, ultracentri- 
fugation [4], FPLC anion exchange [7], and DEAE- 
Sepharose ion-exchange chromatography. Neutraliza- 
tion of cytotoxicity by C sordellii antitoxin did not 
result in inhibition of enolase activity. However, a goat 
antiserum against C. dijficile filtrate abolished enolase 
activity [4], but when the enolase activity and toxin B 
are two closely linked entities as suggested by purifica- 
tion of culture supernatants over DEAE-Sepharose, it
is to he expected that the antiserum contained neutraliz- 
ing antibodies directed against C difficite enolase activ- 
ity and toxin B. 
From these data we conclude that enolase activity is 
not an integral part of the toxin B gene product, but 
toxin B and enolase form a stable complex. 
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